Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

Archive ouverte

Barré, Tangui | Carrat, Fabrice | Ramier, Clémence | Fontaine, Hélène | Di Beo, Vincent | Bureau, Morgane | Dorival, Céline | Larrey, Dominique | Delarocque-Astagneau, Elisabeth | Mathurin, Philippe | Marcellin, Fabienne | Petrov-Sanchez, Ventzislava | Cagnot, Carole | Carrieri, Patrizia | Pol, Stanislas | Protopopescu, Camelia | Alric, Laurent | Pomes, Chloe | Zoulim, Fabien | Maynard, Marianne | Bai, Roxane | Hucault, Lucie | Bailly, François | Raffi, François | Billaud, Eric | Boutoille, David | Lefebvre, Maeva | André-Garnier, Elisabeth | Cales, Paul | Hubert, Isabelle | Lannes, Adrien | Lunel, Françoise | Boursier, Jérôme | Asselah, Tarik | Boyer, Nathalie | Giuily, Nathalie | Castelnau, Corinne | Scoazec, Giovanna | Rousseaud, Emilie | Vallet-Pichard, Anaïs | Sogni, Philippe | de Ledinghen, Victor | Foucher, Juliette | Hiriart, Jean-Baptiste | M’bouyou, Jancell | Irlès-Depé, Marie | Bourlière, Marc | Ahmed, Si Nafa Si | Oules, Valérie | Tran, Albert | Anty, Rodolphe | Gelsi, Eve | Truchi, Régine | Thabut, Dominique | Hammeche, Saloua | Moussali, Joseph | Causse, Xavier | de Dieuleveult, Barbara | Ouarani, Brahim | Labarrière, Damien | Ganne, Nathalie | Grando-Lemaire, Véronique | Nahon, Pierre | Brulé, Séverine | Ulker, Betul | Guyader, Dominique | Jezequel, Caroline | Brener, Audrey | Laligant, Anne | Rabot, Aline | Renard, Isabelle | Habersetzer, François | Baumert, Thomas | Doffoel, Michel | Mutter, Catherine | Simo-Noumbissie, Pauline | Razi, Esma | Bronowicki, Jean-Pierre | Barraud, Hélène | Bensenane, Mouni | Nani, Abdelbasset | Hassani-Nani, Sarah | Bernard, Marie-Albertine | Pageaux, Georges-Philippe | Meszaros, Magda | Metivier, Sophie | Bureau, Christophe | Morales, Thibault | Peron, Jean Marie | Robic, Marie Angèle | Decaens, Thomas | Faure, Marine | Froissart, Bruno | Hilleret, Marie-Noelle | Zarski, Jean-Pierre | Riachi, Ghassan | Goria, Odile | Paris, Fatima | Montialoux, Hélène | Leroy, Vincent | Amaddeo, Giuliana | Varaut, Anne | Simoes, Mélanie | Amzal, Rachida | Chazouillières, Olivier | Andreani, Tony | Angoulevant, Bénédicte | Chevance, Azeline | Serfaty, Lawrence | Samuel, Didier | Antonini, Teresa | Coilly, Audrey | Duclos-Vallée, Jean-Charles | Tateo, Mariagrazia | Abergel, Armand | Reymond, Maud | Brigitte, Chanteranne | Benjamin, Buchard | Muti, Léon | Geist, Claire | Conroy, Guillaume | Riffault, Raphaëlle | Rosa, Isabelle | Barrault, Camille | Costes, Laurent | Hagège, Hervé | Loustaud-Ratti, Véronique | Carrier, Paul | Debette-Gratien, Maryline | Lassailly, Guillaume | Lemaitre, Elise | Canva, Valérie | Dharancy, Sébastien | Louvet, Alexandre | Minello, Anne | Latournerie, Marianne | Bardou, Marc | Mouillot, Thomas | D’alteroche, Louis | Barbereau, Didier | Nicolas, Charlotte | Elkrief, Laure | Jaillais, Anaïs | Gournay, Jérôme | Chevalier, Caroline | Archambeaud, Isabelle | Habes, Sarah | Portal, Isabelle | Gelu-Simeon, Moana | Saillard, Eric | Lafrance, Marie-Josée | Catherine, Lucie | Chau, Frederic | Goderel, Isabelle | Lusivika-Nzinga, Clovis | Bellance, Marc-Antoine | Bellet, Jonathan | Monfalet, Priscilla | Chane-Teng, Jessica | Bijaoui, Sephora | Pannetier, Grégory | Téoulé, François | Nicol, Jérôme | Sebal, Florian | Bekhti, Rafika | Boston, Anaïs | Nailler, Laura | Le Meut, Guillaume | Diallo, Alpha | Fourati, Slim | Housset, Chantal | Bruyand, Mathias | Wittkop, Linda | Zucman-Rossi, Jessica | L’hennaff, Marianne | Sizorn, Michèle

Edité par CCSD ; Institute of Cannabis Research -

International audience. Background: Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated with lower corpulence in various populations. However, this relationship has not yet been studied in persons with chronic HCV infection.Methods: Using baseline data from the French ANRS CO22 Hepather cohort, we used binary logistic and multinomial logistic regression models to test for an inverse relationship between cannabis use (former/current) and (i) central obesity (i.e., large waist circumference) and (ii) overweight and obesity (i.e., elevated body mass index (BMI)) in patients from the cohort who had chronic HCV infection. We also tested for relationships between cannabis use and both waist circumference and BMI as continuous variables, using linear regression models.Results: Among the 6348 participants in the study population, 55% had central obesity, 13.7% had obesity according to their BMI, and 12.4% were current cannabis users. After multivariable adjustment, current cannabis use was associated with lower risk of central obesity (adjusted odds ratio, aOR [95% confidence interval, CI]: 0.45 [0.37-0.55]), BMI-based obesity (adjusted relative risk ratio (aRRR) [95% CI]: 0.27 [0.19-0.39]), and overweight (aRRR [95% CI]: 0.47 [0.38-0.59]). This was also true for former use, but to a lesser extent. Former and current cannabis use were inversely associated with waist circumference and BMI.Conclusions: We found that former and, to a greater extent, current cannabis use were consistently associated with smaller waist circumference, lower BMI, and lower risks of overweight, obesity, and central obesity in patients with chronic HCV infection. Longitudinal studies are needed to confirm these relationships and to assess the effect of cannabis use on corpulence and liver outcomes after HCV cure.Trial registration: ClinicalTrials.gov identifier: NCT01953458 .

Suggestions

Du même auteur

Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort)

Archive ouverte | Barré, Tangui | CCSD

International audience. Background: Chronic hepatitis B virus (HBV) infection may evolve into cirrhosis and hepatocellular carcinoma, and this progression may be accelerated by specific risk factors, including overw...

Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort.

Archive ouverte | Pol, Stanislas | CCSD

International audience. Background: Chronic hepatitis B virus (HBV) infection results in a high risk of cirrhosis and its complications, cirrhosis decompensation (DC), hepatocellular carcinoma (HCC), liver transplan...

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Archive ouverte | Pageaux, Georges‐philippe | CCSD

International audience. BACKGROUND: In HCV-infected patients with advanced liver disease, the direct antiviral agents-associated clinical benefits remain debated. We compared the clinical outcome of patients with a ...

Chargement des enrichissements...